4//SEC Filing
Monroe Terilyn J. 4
Accession 0001652956-26-000002
CIK 0001576280other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:01 PM ET
Size
12.5 KB
Accession
0001652956-26-000002
Insider Transaction Report
Form 4
Monroe Terilyn J.
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-01+14,896→ 35,886 total - Exercise/Conversion
Common Stock
2026-01-01+2,659→ 38,545 total - Tax Payment
Common Stock
2026-01-01$102.14/sh−7,524$768,501→ 31,021 total - Exercise/Conversion
Performance-Based Restricted Stock Units
2026-01-01−14,896→ 14,898 totalExercise: $0.00→ Common Stock (14,896 underlying) - Exercise/Conversion
Restricted Stock Units
2026-01-01−2,659→ 18,615 totalExercise: $0.00→ Common Stock (2,659 underlying)
Footnotes (4)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.
- [F3]Not applicable for Restricted Stock Units.
- [F4]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001652956
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:01 PM ET
- Size
- 12.5 KB